emergency stage The Covid-19 epidemic is over — at least officially. The World Health Organization declared the end of the Covid global health emergency last week, and the United States plans to end the Covid federal public health emergency on Thursday. It will be done one year after you move to do so.
As global and national officials roll back the extensive data tracking, intergovernmental coordination, and testing programs that have been typical of the emergency phase of the pandemic, the move has learned what it has learned from the three-year battle. It raises questions about who it is. Vulnerabilities that could be exposed if a new serious Covid variant (or an entirely new pathogen) emerges.
Josh Michaud, Associate Director of Global Health Policy at the Kaiser Family Foundation, a nonprofit research group, said: Many serious problems persisted during the pandemic, including underfunding for the pandemic response, inequitable distribution of tests and vaccines, and inadequate public messaging. “There is good reason to believe that if we do not fix these institutions and processes, future pandemics will follow the same path,” he says.
New cases, hospitalizations, and deaths are all trending downward in the United States, according to data from the U.S. Centers for Disease Control and Prevention. This also applies to the number of cases and deaths in the EU. But once the U.S. ends her May 11 state of emergency, the CDC will stop tracking community-level infections and instead track overall hospitalization and death rates. The state of emergency mandated the provision of local data, but this is no longer valid.
Fewer data also make it harder to track new variants, complicating the puzzle of updating vaccines to provide maximum protection, while wastewater monitoring and genome surveillance in some regions. will continue. Fewer data will be available when new variants begin to circulate and Covid-19 rages in the fall. At-home testing always fills a gap in national statistics and viral gene sequencing efforts, said Peter Hotes, co-director of the Texas Children’s Hospital Vaccine Development Center and dean of the National School of Tropical Medicine at Baylor College of Medicine. But now he says, “We’re flying blind.”
The shift also makes it harder for public health officials to communicate how serious a risk future variants might be. Sam Scarpino, professor of health sciences and computer science at Northeastern University, said: Without that trust, it will be difficult to get public buy-in for the latest vaccines or a return to masks and social distancing. According to the CDC, only 17% in the US got his bivalent booster injection last year, and only 14% in the EU got his third booster injection.
